Viemed Healthcare, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +23.1%
EBITDA: +24.8%
EBIT: +22.9%
EPS: +21.9%
Free cash flow: +500.0%
Operating cash flow: +40.1%

Forward estimates

Revenue: -39.4%
EBITDA: -31.1%
EPS: -35.4%

Three-year CAGR

Revenue: +24.9%
EBITDA: +27.6%
EBIT: +35.9%
Net income: +33.9%
EPS: +36.3%
Free cash flow: +35.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.